• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.32% Nasdaq Down0.92%

    Evoke Pharma, Inc. (EVOK)

    -NasdaqCM
    6.47 Down 0.06(0.92%) 3:50PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development3,088  2,875  1,852  636  
    Selling General and Administrative733  617  1,070  944  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (3,821) (3,492) (2,923) (1,581)
    Income from Continuing Operations
    Total Other Income/Expenses Net2  3  4  4  
    Earnings Before Interest And Taxes(3,819)(3,489)(2,919)(1,576)
    Interest Expense6  58  37  40  
    Income Before Tax(3,825)(3,547)(2,955)(1,617)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,825)(3,547)(2,955)(1,617)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,825) (3,547) (2,955) (1,617)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (3,825) (3,547) (2,955) (1,617)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.